This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa
The drug VIAGRA contains one active pharmaceutical ingredient (API):
1
Sildenafil
UNII BW9B0ZE037 - SILDENAFIL CITRATE
|
Sildenafil is a potent and selective inhibitor of cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5), the enzyme that is responsible for degradation of cGMP. Apart from the presence of this enzyme in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
VIAGRA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
VIAGRA Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
G04BE03 | Sildenafil | G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 4584G, 4585H, 4586J |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 552819120061317, 552819120061417, 552819120061517, 552819120061617, 552819120061717, 552819120061817 |
Country: CA | Health Products and Food Branch | Identifier(s): 02239766, 02239767, 02239768 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 24.867-12-02, 29661-1-02-11, 5478-MEE-0920 |
Country: EE | Ravimiamet | Identifier(s): 1064203, 1064214, 1064225, 1215324, 1215335, 1215346, 1215357, 1215368, 1215379, 1344956, 1344967, 1344978, 1613382, 1613393, 1613405, 1613416, 1697687, 1697733 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 98077002, 98077006, 98077006IP, 98077006IP1, 98077006IP2, 98077007, 98077007IP, 98077010, 98077010IP, 98077010IP2, 98077011, 98077011IP, 98077014 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 520288, 520338, 520346, 520379, 530584, 530626 |
Country: FR | Base de données publique des médicaments | Identifier(s): 63593884, 64669331, 68107934 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 139703, 147570, 147571, 147579, 21513, 21514, 21522, 21524, 21531, 21533, 355851, 355852, 375370, 375372, 381739, 391794 |
Country: HK | Department of Health Drug Office | Identifier(s): 45575, 45576, 45577, 63095 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 51601, 51730, 51744, 51756, 51760, 51785, 51787, 57439 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 3673, 3674, 3675, 3678, 3679, 3716 |
Country: IT | Agenzia del Farmaco | Identifier(s): 034076024, 034076036, 034076048, 034076063, 034076075, 034076087, 034076101, 034076113, 034076125, 034076137, 034076149, 034076152, 034076164, 034076176, 034076188, 034076190, 034076202, 034076214, 034076226, 034076238, 034076240, 034076253, 043765015, 044548016, 045404011, 045422019, 045422021, 046121012, 046121024, 049589017, 049589029, 050067014, 050829011, 050829023 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2590018F1020, 2590018F2026, 2590018F3022, 2590018F4029 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1008939, 1008941, 1008943, 1031173, 1031174, 1031175, 1031176, 1031177, 1031178, 1031179, 1031180, 1031181, 1034202, 1034203, 1034204, 1034205, 1071827, 1071828, 1071829, 1071830, 1079164, 1079165 |
Country: MT | Medicines Authority | Identifier(s): MA1396/01401 |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 134M2010, 213M98 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 51063, 51071, 51098 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 8165, 8166, 8167 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100085594, 100085602, 100085619, 100297050, 100373181, 100399602 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W66751001, W66751002, W66751003, W66751004, W66752001, W66752002, W66752003, W66752004, W66753001, W66753002, W66753003, W66753004, W66754001, W66754002, W66754003, W66754004 |
Country: SG | Health Sciences Authority | Identifier(s): 10804P, 10805P, 10806P, 14605P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 25603021, 25603022, 25603023, 8013121, 8013123 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699532057549, 8699532059680, 8699532059703, 8699532059710, 8699532090010, 8699532090027, 8699532090034, 8699532092700, 8699532092717, 8699532095909 |
Country: US | FDA, National Drug Code | Identifier(s): 0069-4200, 0069-4210, 0069-4220, 43063-256, 43353-764, 50090-0619, 55154-2736, 63539-421, 63539-422, 63629-6316, 63629-6369, 63629-7273, 67544-355, 67544-356 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 32/7.1.5/0621, 32/7.1.5/0622, 32/7.1.5/0623, 32/7.1.5/0624, 32/7.1.5/0625, 32/7.1.5/0626 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.